Electric knee sleeve aims to speed up ACL recovery in cadets

NCT ID NCT06341868

Recruiting now Disease control Sponsor: Keller Army Community Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a wearable electrical stimulation sleeve called KneeStim in 60 military cadets recovering from ACL reconstruction. Half will use the device during rehab and daily tasks for 12 weeks, while the other half gets standard care with a low-intensity version. Researchers will measure changes in walking and running patterns, muscle mass, and how quickly cadets return to full duty.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: KneeStim device (wearable electrical stimulation knee sleeve)
What this could lead to: If it works, this could lead to faster and more complete recovery of walking and running after ACL surgery.
What could go wrong: This is a small, early-stage trial with only 60 participants, so results may not apply to the general public. The device may not improve outcomes beyond standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTERIOR CRUCIATE LIGAMENT INJURIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Anterior Cruciate Ligament Injuries

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANTERIOR CRUCIATE LIGAMENT INJURIES

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Keller Army Community Hospital
RECRUITING

West Point, New York, 10996, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.